Can a digital pen “revolutionise” Parkinson’s diagnosis?

News

Author: Sophie BatesPublished: 23 January 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Parkinson's diagnosis pen

A Parkinson’s diagnosing pen has sealed a five-year manufacturing deal from stationery brand Stabilo.

The Neuromotor Pen– developed by Scottish medical devices company Manus Neurodynamica – analyses a user’s hand and limb movements as they perform a number of drawing tests on a tablet.

Microchips within the device record the data of even the smallest of movements, and determine whether a user has Parkinson’s in a simple and non-invasive way.

Researchers believe the pen could be adapted in the future for use in monitoring patients with Alzheimer’s, multiple sclerosis and those that have suffered from a stroke.

Peter Kämpf, director of research and development at Schwan-Stabilo, said: “This novel product can potentially revolutionise the diagnosis and treatment of neuromotor diseases, and we are excited to be involved in its development and in helping bring it to market.”

To read more on this topic click here.


Read more:

Scotland sees soaring Parkinson’s rate

Over a quarter of people living with Parkinson’s were initially misdiagnosed, study finds

Go Back

Share this story

Comments


Related articles


various currencies on the table

PD in Practice

Early Parkinson’s intervention could “save governments millions”

A survey is investigating the economic impact of Parkinson's

READ MORE

Advances

New technology helps prevent PwPs from falling

Innovative remote management gait guidance system is to launch soon

READ MORE
Anne and Mike Mikkelsen

Carers' Corner

Advanced Parkinson’s: a survivor’s guide to ‘transcending the pain of death’

Book review: ‘Love’s Last Measure’ by Anne Mikkelsen

READ MORE